Hypertension Drugs

Hypertension Drugs is a fast, evidence-based reference to antihypertensive prescribing for healthcare professionals, trainees and students. Built around NICE NG136, ESC/ESH 2023 and BHS guidance, it puts every major drug class, dose and landmark trial one tap away — with a clean, distraction-free interface designed for the ward, clinic and exam revision.

INTERACTIVE TREATMENT ALGORITHM
- Tap-through NICE NG136 first-line selector — choose age, ethnicity and diabetes status to see the recommended Step 1 agent and rationale
- The full A / C / D step ladder from Step 1 to resistant hypertension
- Clinic and ABPM/HBPM blood pressure targets, including over-80s, diabetes and CKD

SEVEN DRUG CLASSES, 30+ DRUGS
- ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, diuretics and other agents
- Doses for hypertension, heart failure, post-MI and specialist indications
- UK brand names, titration steps and practical prescribing notes
- Side effects, monitoring schedules and contraindications at a glance

KEY TRIALS AT YOUR FINGERTIPS
- HOPE, ASCOT, RALES, ALLHAT, LIFE, PATHWAY-2, PARADIGM-HF, PROGRESS, ONTARGET and more
- Why each trial matters, summarised in plain clinical language

CLINICAL DECISION SUPPORT
- Compelling indications — drug choice guided by comorbidity (HFrEF, post-MI, diabetes, CKD, AF, stroke, pregnancy, gout and more)
- Resistant hypertension — definition, secondary-cause screen and PATHWAY-2 Step 4 strategy
- Hypertensive emergencies: emergency vs urgency, target-organ damage, controlled BP-lowering targets and IV agents

DESIGNED FOR CLINICIANS
- Works fully offline — no sign-in, no ads, no tracking
- Adjustable text size for quick bedside reading
- Clear source citations throughout and a dedicated References screen
- One-time purchase to unlock the full library — no subscription

WHO IT'S FOR
Foundation doctors, IMT and specialty trainees, GPs, hospital pharmacists, advanced nurse practitioners, and medical, nursing and pharmacy students preparing for exams or working on the wards.

GUIDELINES & SOURCES
Based on NICE NG136 (2023), NICE NG133 (hypertension in pregnancy), ESC/ESH 2023, British Hypertension Society guidance and the British National Formulary, plus the landmark randomised trials that underpin modern antihypertensive practice.

IMPORTANT — EDUCATIONAL & TRAINING USE ONLY
This app is intended for education and training. It is not a substitute for clinical judgement and is not for use as sole clinical guidance, nor is it a regulated medical device. Always verify doses against the current BNF and follow local protocols. Developed by Dr Atif Elnil, MBBS MRCP, Neurology Department, St George's, London.